• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Manufacturing
    • Packaging
    • Development
    • Compliance
    • Top 25
    • Directory
    • Microsites
    • Events
    • More
  • Magazine
  • News
  • Manufacturing
  • Packaging
  • Development
  • Compliance
  • Top 25
  • Directory
  • Microsites
  • Events
  • Current / Back Issue
    Features
    Editorial
    Columns
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Subscribe Now
    Advertise Now
    Top Features
    DCAT Week ’19

    Temperature-Controlled Logistics

    Reducing Pill Burden

    Nasal Drug Delivery

    AI in Pharma: Transforming Data into Drugs
    Breaking News
    Online Exclusives
    Industry News
    Collaborations & Alliances
    Promotions & Moves
    Trials & Filings
    Financial Reports
    Bio News & Views
    Custom Sourcing News
    Packaging & Tracking
    CRO News
    Live From Shows
    Top News
    AGC, Calypso Form Devt./Mfg. Deal

    Quanticate Appoints SVP of Project Delivery

    Alkermes, Clovis Form Cancer Research Collaboration

    APC Expands to U.S. with Opening of MA Facility

    Evotec & HZI Parnter for Novel Antibiotics
    APIs
    Aseptic Processing
    Cleaning Validation
    Clinical Trial Materials
    Cytotoxics and High Potency Manufacturing
    Equipment
    Excipients
    Extractables and Leachables
    Facilities
    Fill/Finish
    Lyophilization
    Parenterals
    Process Development
    Process Validation
    Risk Management
    Scale-up/ Technology Transfer
    Solid Dosage/ Creams/ Ointments

    ACG Capsules Expands in Brazil

    AGC, Calypso Form Devt./Mfg. Deal

    APC Expands to U.S. with Opening of MA Facility

    Catalent Enters Clinical Supply Partnership with Adial

    Catalent Receives P&G Award
    Capsules
    Cold Chain Management
    Injectables
    Logistics
    Serialization
    Solid Dosage / Semi-solids
    Supply Chain
    Vials

    ACG Capsules Expands in Brazil

    Catalent Receives P&G Award

    GS1 Delivers Lightweight Messaging Standard For Verification of Product Identifiers

    Pelican BioThermal Opens New Network Location

    Reed-Lane Facility Tour
    Analytical Services
    Bioanalytical Services
    Bioassay Developement
    Biologics, Proteins, Vaccines
    Biosimilars
    Chemistry
    Clinical Trials
    Drug Delivery
    Drug Development
    Drug Discovery
    Formulation Development
    Information Technology
    Laboratory Testing
    Methods Development
    Microbiology
    Preclinical Outsourcing
    R&D
    Toxicology

    Quanticate Appoints SVP of Project Delivery

    Alkermes, Clovis Form Cancer Research Collaboration

    APC Expands to U.S. with Opening of MA Facility

    Evotec & HZI Parnter for Novel Antibiotics

    Pii Inks Devt. Deal with Nemus
    Filtration & Purification
    GMPs/GCPs
    Inspections
    QA/QC
    Regulatory Affairs
    Validation

    Former FDA Senior Executives Join PAREXEL

    Top Global Pharma Company to Implement ValGenesis' VLMS

    WCG, Prudentia Enter Pharmacovigilance Alliance

    ValGenesis VLMS Chosen to Digitize Validation Process

    Serialization Compliance: Understanding the Challenges
    Companies
    Categories
    Corporate Capabilities
    Add New Company
    Contract Service Directory Companies
    Alcami

    Reed-Lane, Inc.

    Baxter BioPharma Solutions

    Vetter Pharma International GmbH

    Ascendia Pharmaceuticals
    Companies
    News Releases
    Posters
    Brochures
    Services
    Videos
    Case Study
    White Papers
    Jobs
    Contract Service Directory Companies
    Reed-Lane, Inc.

    Aphena Pharma Solutions, Inc.

    Ascendia Pharmaceuticals

    Federal Equipment Company

    Vetter Pharma International GmbH
    Webinars
    Live From Shows
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
      • Enewsletter Archive
      • Digital Edition
    • Directory
      • Companies
      • Categories
      • Corporate Capabilities
      • Add Your Company
    • Manufacturing
      • APIs
      • Aseptic Processing
      • Cleaning Validation
      • Clinical Trial Materials
      • Cytotoxics and High Potency Manufacturing
      • Equipment
      • Excipients
      • Extractables and Leachables
      • Facilities
      • Fill/Finish
      • Lyophilization
      • Parenterals
      • Process Development
      • Process Validation
      • Risk Management
      • Scale-up/ Technology Transfer
      • Solid Dosage/ Creams/ Ointments
      • cGMP Manufacture
    • Packaging
      • Capsules
      • Cold Chain Management
      • Injectables
      • Logistics
      • Serialization
      • Solid Dosage / Semi-solids
      • Supply Chain
      • Vials
    • Development
      • Analytical Services
      • Bioanalytical Services
      • Bioassay Developement
      • Biologics, Proteins, Vaccines
      • Biosimilars
      • Chemistry
      • Clinical Trials
      • Drug Delivery
      • Drug Development
      • Drug Discovery
      • Formulation Development
      • Information Technology
      • Laboratory Testing
      • Methods Development
      • Microbiology
      • Preclinical Outsourcing
      • R&D
      • Toxicology
    • Compliance
      • Filtration & Purification
      • GMPs/GCPs
      • Inspections
      • QA/QC
      • Regulatory Affairs
      • Validation
    • Top 25 Pharma & BioPharma
      • Top 20 Pharma & BioPharma
      • Top 10 BioPharma Companies
    • Contract Pharma Direct
    • Breaking News
    • Online Exclusives
    • Slideshows
    • Experts Opinions
    • Surveys
      • Outsourcing Survey
      • Salary Survey
    • Glossary
    • Videos
    • White Papers
    • Infographics
    • Contract Pharma Conference
      • Contract Pharma Conference
      • Speakers
      • Exhibitors
      • Agenda
      • Conference Sessions
    • Supplier Microsite
      • Companies
      • News Releases
      • Posters
      • Brochures
      • Services
      • Videos
      • Case Study
      • White Papers
    • eBook
    • Webinars
    • Events
      • Industry Events
      • Live from Show Events
      • Webinars
    • Classifieds / Job Bank
      • Classifieds
      • Job Bank
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Breaking News

    Xspray, NerPharMa Sign Manufacturing and Supply Agreement

    For the clinical and world-wide commercial supply of HyNap-Dasa

    Related CONTENT
    • Neuland Unveils Dedicated Process Engineering Lab
    • Senate Passes FDA Reauthorization Act
    • Valeant's Tampa Facility Receives FDA VAI Classification
    • FDA Reauthorization Act Signed into Law
    • Cancer Trials in the New Age of Drug Development
    12.27.17

    Xspray Pharma AB has signed a manufacturing and supply agreement with NerPharMa to manufacture its lead product candidate, HyNap-Dasa. 

     

    The agreement covers the clinical and world-wide commercial supply of HyNap-Dasa, and includes production of both drug substance and the finished product. HyNap-Dasa is one of three product candidates that Xspray currently has under development. The company's goal is to launch it in the US market in 2021. 

     

    Under the terms of the agreement, Xspray has contracted NerPharMa to manufacture drug substance and the finished product to supply material for clinical programs and for future world-wide commercial sales. Xspray is developing HyNap-Dasa both as a completely interchangeable variant of Sprycel to be registered in the United States by the Abbreviated New Drug Application (ANDA) route or as an improved product by the 505(b)(2) procedure. 

     

    "This contract is a significant step in our development of HyNap-Dasa," said Per Andersson, chief executive officer of Xspray Pharma. "We are pleased to have secured access to GMP production of drug substance and finished product for our continued clinical program as well as to GMP quantities of HyNap-Dasa for future commercial activities in an US FDA approved manufacturing facility."

     
    Related Searches
    • manufacturing and supply agreement
    • production
    • facility
    • fda
    Suggested For You
    PixarBio, Particle Sciences Enter Manufacturing Agreement PixarBio, Particle Sciences Enter Manufacturing Agreement
    FDA Accepts Novartis FDA Accepts Novartis' sNDA for Stage III Melanoma Treatment
    Juno, Thermo Fisher Announce CAR T Manufacturing Partnership Juno, Thermo Fisher Announce CAR T Manufacturing Partnership
    Melinta Buys Infectious Disease Unit from The Medicines Company Melinta Buys Infectious Disease Unit from The Medicines Company
    Arcinova Strengthens API Services with New GMP Mfg. Capabilities Arcinova Strengthens API Services with New GMP Mfg. Capabilities
    Flexible Manufacturing Strategies and Data Integrity Flexible Manufacturing Strategies and Data Integrity
    CEO Spotlight:  Samsung Biologics CEO Spotlight: Samsung Biologics
    Sterile Manufacturing: Future Trends and Challenges Sterile Manufacturing: Future Trends and Challenges
    Piramal Invests $55M to Expand API Mfg. Capabilities Piramal Invests $55M to Expand API Mfg. Capabilities
    Contracting & Outsourcing Session Highlights and Key Takeaways Contracting & Outsourcing Session Highlights and Key Takeaways
    SELLAS, Merck Enter Clinical Trial Collaboration and Supply Pact  SELLAS, Merck Enter Clinical Trial Collaboration and Supply Pact
    Catalent to Acquire Cook Pharmica for $950M Catalent to Acquire Cook Pharmica for $950M
    Know the Challenges of  Biosimilar Manufacturing Know the Challenges of Biosimilar Manufacturing
    Dissolution is King Dissolution is King
    AMRI Introduces Forced Degradation Services AMRI Introduces Forced Degradation Services

    Related Breaking News

    • Bio News | Breaking News | cGMP Manufacture | Collaborations & Alliances | Industry News | Process Development
      AGC, Calypso Form Devt./Mfg. Deal

      AGC, Calypso Form Devt./Mfg. Deal

      Enter agreement for process development and cGMP manufacture of CALY-002
      02.20.19

    • Bio News | Drug Delivery | Industry News | Promotions & Moves
      Quanticate Appoints SVP of Project Delivery

      Quanticate Appoints SVP of Project Delivery

      Paula Finch has over 20 years’ experience of working in statistics and SAS programming for sponsor companies and CROs
      02.20.19

    • Breaking News | Collaborations & Alliances | Industry News | Preclinical Outsourcing
      Alkermes, Clovis Form Cancer Research Collaboration

      Alkermes, Clovis Form Cancer Research Collaboration

      Together will explore combination cancer therapies
      02.20.19


    • Bio News | Facilities | Industry News | Methods Development | Process Development
      APC Expands to U.S. with Opening of MA Facility

      APC Expands to U.S. with Opening of MA Facility

      Business Development, Marketing and Project Management services will operate from the new office space, with possible lab space planned for the future
      02.20.19

    • Breaking News | Collaborations & Alliances | Drug Development | Industry News
      Pii Inks Devt. Deal with Nemus

      Pii Inks Devt. Deal with Nemus

      CDMO to develop dosage formulation for human dosing with NB1111 for glaucoma
      02.20.19

    • Bio News | Collaborations & Alliances | Drug Development | Industry News | Laboratory Testing | R&D
      Evotec & HZI Parnter for Novel Antibiotics

      Evotec & HZI Parnter for Novel Antibiotics

      Research activities will initially be focused on the optimization of cystobactamids
      02.20.19


    • Analytical Services | Bio News | Collaborations & Alliances | Industry News | Information Technology | R&D
      WuXi STA, BioLingus Form Technology Collaboration

      WuXi STA, BioLingus Form Technology Collaboration

      WuXi STA will have exclusive access to BioLingus technology for sublingual and buccal delivery in the CDMO sector
      02.20.19

    • Breaking News | Clinical Trials | Collaborations & Alliances | Drug Development | Industry News

      Gliknik Receives $15M Milestone from Pfizer

      Follows start of Phase 1 trial for Pfizer candidate PF-06755347
      02.20.19

    • Bio News | Collaborations & Alliances | Drug Development | Drug Discovery | Industry News | R&D
      PPD & HLT Enter Development Agreement

      PPD & HLT Enter Development Agreement

      To create data science-driven clinical research solutions in China with the goal of enhancing global drug development
      02.20.19


    • Breaking News | Clinical Trial Materials | Collaborations & Alliances | Industry News | Packaging & Tracking
      Catalent Enters Clinical Supply Partnership with Adial

      Catalent Enters Clinical Supply Partnership with Adial

      Will package and distribute Adial’s AD04 for its Phase 3 trial
      02.20.19

    • Breaking News | Capsules | Collaborations & Alliances | Industry News | Solid Dosage/Creams/Ointments
      Catalent Receives P&G Award

      Catalent Receives P&G Award

      Recognizes the performance of softgel manufacturing facilities in Canada
      02.20.19

    • Breaking News | Promotions & Moves
      BASi Appoints COO

      BASi Appoints COO

      Oakley responsible for leading operations at BASi’s three sites in West Lafayette and Evansville, IN, and St. Louis, MO
      02.19.19

    • Breaking News | Drug Development | Industry News
      Nestlé Health Licenses Codexis’ CDX-6114

      Nestlé Health Licenses Codexis’ CDX-6114

      Novel, oral enzyme for phenylketonuria is Codexis’ first internally developed biotherapeutic candidate
      02.19.19

    • Bio News | Breaking News | Collaborations & Alliances | Drug Development | Industry News
      SK, Arvelle Sign $530M Deal for Antiepileptic Drug

      SK, Arvelle Sign $530M Deal for Antiepileptic Drug

      Mark Altmeyer named president and chief executive of Arvelle
      02.15.19

    • Breaking News | Industry News | Packaging & Tracking | Serialization | Supply Chain
      GS1 Delivers Lightweight Messaging Standard For Verification of Product Identifiers

      GS1 Delivers Lightweight Messaging Standard For Verification of Product Identifiers

      Streamlined framework leverages GS1 Digital Link and JavaScript Object Notation (JSON)
      02.15.19

    Breaking News
    • AGC, Calypso Form Devt./Mfg. Deal
    • Quanticate Appoints SVP of Project Delivery
    • Alkermes, Clovis Form Cancer Research Collaboration
    • APC Expands to U.S. with Opening of MA Facility
    • Pii Inks Devt. Deal with Nemus
    View Breaking News >
    CURRENT ISSUE

    January/February 2019

    • DCAT Week ’19
    • Temperature-Controlled Logistics
    • Reducing Pill Burden
    • Nasal Drug Delivery
    • AI in Pharma: Transforming Data into Drugs
    • Digitization: Pharma 4.0
    • Serialization Compliance: Understanding the Challenges
    • FDA & Data Integrity
    • Rising Demand for Lyophilized Products
    • Future Trends in the CDMO Space
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • privacy policy
    • term and condition
    • about us
    • contact us

    follow us

    Subscribe

    magazines

    Image
    Image
    Image
    Image
    Image
    Image
    Image
    Image
    Image
    Image
    Image

    Copyright © 2019 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login